150 related articles for article (PubMed ID: 36943597)
1. Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease.
Porcaro AB; Panunzio A; Serafin E; Bianchi A; Gallina S; Mazzucato G; Vidiri S; D'Aietti D; Orlando R; Ditonno F; Montanaro F; Marafioti Patuzzo G; Bailelli A; Artoni F; Zecchini Antoniolli S; Rizzetto R; Brunelli M; Siracusano S; Cerruto MA; Tafuri A; Antonelli A
Int Urol Nephrol; 2023 May; 55(5):1139-1148. PubMed ID: 36943597
[TBL] [Abstract][Full Text] [Related]
2. Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mL.
Porcaro AB; Bianchi A; Mazzucato G; Gallina S; Serafin E; Tafuri A; Cerrato C; Panunzio A; Vidiri S; D'Aietti D; Orlando R; Brusa D; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
Int Urol Nephrol; 2023 Jan; 55(1):85-92. PubMed ID: 36197572
[TBL] [Abstract][Full Text] [Related]
3. Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?
Porcaro AB; Bianchi A; Panunzio A; Gallina S; Serafin E; Tafuri A; Trabacchin N; Orlando R; Ornaghi PI; Mazzucato G; Vidiri S; D'Aietti D; Montanaro F; Brusa D; Patuzzo GM; Artoni F; Baielli A; Migliorini F; De Marco V; Veccia A; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38553619
[TBL] [Abstract][Full Text] [Related]
4. Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies.
Ferro M; Lucarelli G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Crocerossa F; Perdonà S; Del Prete P; Cordima G; Musi G; Del Giudice F; Busetto GM; Chung BI; Porreca A; Ditonno P; Battaglia M; Terracciano D
World J Urol; 2021 Jun; 39(6):1861-1867. PubMed ID: 32683462
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy.
Porcaro AB; Tafuri A; Panunzio A; Cerrato C; Bianchi A; Gallina S; Vidiri S; D'Aietti D; Serafin E; Mazzucato G; Princiotta A; Brusa D; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
Asian J Androl; 2023 Jan; 25(5):556-63. PubMed ID: 36629157
[TBL] [Abstract][Full Text] [Related]
6. Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.
Dai B; Qu Y; Kong Y; Ye D; Yao X; Zhang S; Wang C; Zhang H; Yang W
BJU Int; 2012 Dec; 110(11 Pt B):E667-72. PubMed ID: 22974446
[TBL] [Abstract][Full Text] [Related]
7. The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center.
Porcaro AB; Bianchi A; Panunzio A; Gallina S; Tafuri A; Serafin E; Orlando R; Mazzucato G; Vidiri S; D'Aietti D; Montanaro F; Marafioti Patuzzo G; Artoni F; Baielli A; Ditonno F; Rizzetto R; Veccia A; Gozzo A; De Marco V; Brunelli M; Cerruto MA; Antonelli A
Ther Adv Urol; 2024; 16():17562872241229260. PubMed ID: 38348129
[TBL] [Abstract][Full Text] [Related]
8. A risk grouping algorithm for predicting factors of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Micoogullari U; Cakici MC; Kisa E; Canda AE; Kilic FU; Ardicoglu A; Altinova S; Atmaca AF; Akbulut Z; Balbay MD
Int J Clin Pract; 2021 Oct; 75(10):e14495. PubMed ID: 34155724
[TBL] [Abstract][Full Text] [Related]
9. Testosterone as a predictor of pathological stage in clinically localized prostate cancer.
Isom-Batz G; Bianco FJ; Kattan MW; Mulhall JP; Lilja H; Eastham JA
J Urol; 2005 Jun; 173(6):1935-7. PubMed ID: 15879785
[TBL] [Abstract][Full Text] [Related]
10. Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy.
Porcaro AB; Panunzio A; Bianchi A; Cerrato C; Gallina S; Serafin E; Mazzucato G; Vidiri S; D'Aietti D; Orlando R; Brusa D; Brunelli M; Siracusano S; Pagliarulo V; Cerruto MA; Tafuri A; Antonelli A
Ther Adv Urol; 2023; 15():17562872231154150. PubMed ID: 36846295
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of palpable prostate tumors on disease progression after robot-assisted radical prostatectomy: a single-center experience.
Porcaro AB; Gallina S; Bianchi A; Tafuri A; Serafin E; Panunzio A; Mazzucato G; Orlando R; Ditonno F; Ornaghi PI; Rizzetto R; Cerrato C; De Marco V; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
J Robot Surg; 2023 Oct; 17(5):2471-2477. PubMed ID: 37486540
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H
BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348
[TBL] [Abstract][Full Text] [Related]
13. Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results.
Neuzillet Y; Raynaud JP; Dreyfus JF; Radulescu C; Rouanne M; Schneider M; Krish S; Rouprêt M; Drouin SJ; Comperat E; Galiano M; Cathelineau X; Validire P; Molinié V; Fiet J; Giton F; Lebret T; Botto H
Horm Cancer; 2019 Feb; 10(1):36-44. PubMed ID: 30293206
[TBL] [Abstract][Full Text] [Related]
14. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy.
Lane BR; Stephenson AJ; Magi-Galluzzi C; Lakin MM; Klein EA
Urology; 2008 Dec; 72(6):1240-5. PubMed ID: 18692874
[TBL] [Abstract][Full Text] [Related]
15. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection.
Porcaro AB; Panunzio A; Tafuri A; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Gozzo A; Serafin E; Cianflone F; Migliorini F; Vidiri S; Di Filippo G; Novella G; Brunelli M; Shakir A; Pagliarulo V; Cerruto MA; Siracusano S; Antonelli A
Urol Int; 2022; 106(9):928-939. PubMed ID: 35081537
[TBL] [Abstract][Full Text] [Related]
17. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
[TBL] [Abstract][Full Text] [Related]
18. Robot-assisted laparoscopic radical prostatectomy in patients with prostate cancer with high-risk features: predictors of favorable pathologic outcome.
Uberoi J; Brison D; Patel N; Sawczuk IS; Munver R
J Endourol; 2010 Mar; 24(3):403-7. PubMed ID: 20078237
[TBL] [Abstract][Full Text] [Related]
19. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
Koie T; Mitsuzuka K; Yoneyama T; Narita S; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C; Yoneyama T; Tobisawa Y
Int J Clin Oncol; 2015 Feb; 20(1):176-81. PubMed ID: 24771079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
